Literature DB >> 19325034

NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.

Barbara Morandi1, Lorenzo Mortara, Paolo Carrega, Claudia Cantoni, Gregorio Costa, Roberto S Accolla, Maria Cristina Mingari, Silvano Ferrini, Lorenzo Moretta, Guido Ferlazzo.   

Abstract

NK cell recognition of cells that do not express or express low amounts of MHC class I molecules results not only in direct killing of target cells but also in the generation of specific T cell responses consequent to the induction of dendritic cell (DC) activation. While IL-12 production by NK cell-activated DCs is generally thought to play a critical role, a similar DC-mediated NK cell help has been reported also in IL-12-knockout mice. Here, we show that human NK cells can induce on DC surface membrane, via IFN-gamma secretion, the expression of high levels of IL-15. Remarkably, we show that DC expression of this membrane-bound form of IL-15, which is only partially associated with IL-15R molecules, is essential to promote specific CD8(+) T lymphocyte response in the absence of DC-derived IL-12.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325034     DOI: 10.1093/intimm/dxp029

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  19 in total

1.  Decreased Interferon γ Production in CD3+ and CD3- CD56+ Lymphocyte Subsets in Metastatic Regional Lymph Nodes of Melanoma Patients.

Authors:  Ana Vuletić; Irena Jovanić; Vladimir Jurišić; Zorka Milovanović; Srđan Nikolić; Igor Spurnić; Gordana Konjević
Journal:  Pathol Oncol Res       Date:  2015-05-03       Impact factor: 3.201

Review 2.  Liaison between natural killer cells and dendritic cells in human gestation.

Authors:  Ester Leno-Durán; Raquel Muñoz-Fernández; Enrique García Olivares; Irene Tirado-González
Journal:  Cell Mol Immunol       Date:  2014-06-23       Impact factor: 11.530

3.  IL-15-deficient mice develop enhanced allergic responses to airway allergen exposure.

Authors:  C B Mathias; C M Schramm; L A Guernsey; C A Wu; S H Polukort; J Rovatti; J Ser-Dolansky; E Secor; S S Schneider; R S Thrall; H L Aguila
Journal:  Clin Exp Allergy       Date:  2017-02-07       Impact factor: 5.018

4.  Acute Virus Control Mediated by Licensed NK Cells Sets Primary CD8+ T Cell Dependence on CD27 Costimulation.

Authors:  Jeffrey J Teoh; Awndre E Gamache; Alyssa L Gillespie; Michael D Stadnisky; Hideo Yagita; Timothy N J Bullock; Michael G Brown
Journal:  J Immunol       Date:  2016-10-24       Impact factor: 5.422

Review 5.  Engineering dendritic cells to enhance cancer immunotherapy.

Authors:  Jeanette E Boudreau; Aude Bonehill; Kris Thielemans; Yonghong Wan
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

Review 6.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

7.  Characterization of human afferent lymph dendritic cells from seroma fluids.

Authors:  Barbara Morandi; Irene Bonaccorsi; Mario Mesiti; Romana Conte; Paolo Carrega; Gregorio Costa; Raffaella Iemmo; Stefania Martini; Soldano Ferrone; Claudia Cantoni; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

Review 8.  Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics.

Authors:  Valeria Rizzello; Irene Bonaccorsi; Maria Luisa Dongarrà; Lisbeth Nielsen Fink; Guido Ferlazzo
Journal:  J Biomed Biotechnol       Date:  2011-05-03

Review 9.  Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions.

Authors:  Loredana Frasca; Roberto Lande
Journal:  ScientificWorldJournal       Date:  2011-11-01

Review 10.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.